Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-11-000072
Filing Date
2011-08-03
Accepted
2011-08-03 16:45:14
Documents
2
Period of Report
2011-08-03

Document Format Files

Seq Description Document Type Size
1 6K FORM form6-k.htm 6-K 24337
2 Q2 CERTIFICATES ex99.htm EX-99.1 38852
  Complete submission text file 0001129928-11-000072.txt   64201
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 111007437
SIC: 2834 Pharmaceutical Preparations